A developer of novel anti-infective drug candidates targeting specific pathogens that cause serious infections and diseases, including C. difficile, constipation-predominant irritable bowel syndrome, Pertussis, Acinetobacter and multiple sclerosis
Follow Twitter.com/InvestorsGuru for US/Cdn small-cap breakout stocks - active uptrending movers with news. Guru Trader Videos go into detail about some of these stocks. Let's discover fast growing small-caps together! Signup for our Free Newsletter!